NanoEcho AB (publ) (STO:NANECH)

Market Cap	12.45M -67.1%
Revenue (ttm)	1.13M -93.3%
Net Income	-14.56M
EPS	-0.04
Shares Out	457.54M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,457,939
Open	0.0292
Previous Close	0.0292
Day's Range	0.0256 - 0.0292
52-Week Range	0.0200 - 0.1396
Beta	0.63
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About NanoEcho AB

NanoEcho AB (publ) engages in developing a new diagnostic method to determine the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is headquartered in Lund, Sweden.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2013
• Employees: 5
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: NANECH

Financial Performance

In 2025, NanoEcho AB's revenue was 487,000, a decrease of -93.30% compared to the previous year's 7.27 million. Losses were -15.65 million, 3.35% more than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 4, 2026

Data Sources Report a data error